Acro Biomedical (ACBM) EBIT Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 78.40% |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | -183.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -183.52% |
| Sep 30, 2025 | -1,163.99% |
| Jun 30, 2025 | -49.83% |
| Mar 31, 2025 | 13.25% |
| Dec 31, 2024 | -99.72% |
| Sep 30, 2024 | 99.43% |
| Jun 30, 2024 | 99.72% |
| Mar 31, 2024 | 99.74% |
| Dec 31, 2023 | 276.35% |
| Sep 30, 2023 | 60.39% |
| Jun 30, 2023 | 20.06% |
| Mar 31, 2023 | -1.91% |
| Dec 31, 2022 | -2.11% |
| Sep 30, 2022 | -34.11% |
| Jun 30, 2022 | -403.76% |
| Mar 31, 2022 | -6,793.35% |
| Sep 30, 2021 | -4,080.34% |
| Jun 30, 2021 | -1,163.83% |
| Mar 31, 2021 | -169.88% |
| Sep 30, 2020 | -10.99% |
| Jun 30, 2020 | 7.81% |
| Mar 31, 2020 | 137.97% |
| Dec 31, 2019 | 19.95% |
| Sep 30, 2019 | -140.02% |
| Jun 30, 2019 | -138.64% |
| Mar 31, 2019 | -319.12% |
| Dec 31, 2018 | -217.46% |
| Sep 30, 2018 | 307.86% |
| Jun 30, 2018 | 1,582.51% |
| Mar 31, 2018 | 536.71% |
| Dec 31, 2017 | 1,182.25% |